pmc logo image
Logo of jcinvestCurrent issueArchiveSubscribe to the JCIAbout the JCIThe Journal of Clinical Investigation
Journal List > J Clin Invest > v.83(3); Mar 1989

Formats:
J Clin Invest. 1989 March; 83(3): 764–770.
doi: 10.1172/JCI113955.
PMCID: PMC303745
Copyright notice
Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter.
B Grubeck-Loebenstein, G Buchan, R Sadeghi, M Kissonerghis, M Londei, M Turner, K Pirich, R Roka, B Niederle, H Kassal
, et al.
Charing Cross Sunley Research Centre, London, United Kingdom.
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
The production and growth regulatory activity of transforming growth factor beta were studied in human thyroid tissue. As estimated by its mRNA expression in fresh tissue samples, transforming growth factor beta was produced in normal and in diseased thyroid glands. Transforming growth factor beta mRNA was mainly produced by thyroid follicular cells and in lesser quantities by thyroid infiltrating mononuclear cells. The concentrations of transforming growth factor beta mRNA were lower in iodine-deficient nontoxic goiter than in Graves' disease and normal thyroid tissue. Transforming growth factor beta protein secretion by cultured thyroid follicular cells was also low in nontoxic goiter, but could be increased by addition of sodium iodide (10 microM) to the culture medium. Recombinant transforming growth factor beta did not affect basal tritiated thymidine incorporation in cultured thyroid follicular cells, but inhibited, at a concentration of 10 ng/ml, the growth stimulatory influence of insulin-like growth factor I, epidermal growth factor, transforming growth factor alpha, TSH, and partly that of normal human serum on cultured thyroid follicular cells. This inhibition was greater in Graves' disease than in nontoxic goiter. These results suggest that transforming growth factor beta may act as an autocrine growth inhibitor on thyroid follicular cells. Decreased transforming growth factor beta production and decreased responsiveness to transforming growth factor beta may be cofactors in the pathogenesis of iodine-deficient nontoxic goiter.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 764
764
icon of scanned page 765
765
icon of scanned page 766
766
icon of scanned page 767
767
icon of scanned page 768
768
icon of scanned page 769
769
icon of scanned page 770
770
 
Images in this article
Image
Image
Image on p.766
Image
Image
Image on p.766
Image
Image
Image on p.766
Click on the image to see a larger version.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Westermark K, Westermark B. Mitogenic effect of epidermal growth factor on sheep thyroid cells in culture. Exp Cell Res. 1982 Mar;138(1):47–55. [PubMed]
  • Westermark K, Karlsson FA, Westermark B. Epidermal growth factor modulates thyroid growth and function in culture. Endocrinology. 1983 May;112(5):1680–1686. [PubMed]
  • Eggo MC, Bachrach LK, Fayet G, Errick J, Kudlow JE, Cohen MF, Burrow GN. The effects of growth factors and serum on DNA synthesis and differentiation in thyroid cells in culture. Mol Cell Endocrinol. 1984 Dec;38(2-3):141–150. [PubMed]
  • Eggo MC, Bachrach LK, Burrow GN. Role of non-TSH factors in thyroid cell growth. Acta Endocrinol Suppl (Copenh). 1987;281:231–237. [PubMed]
  • Assoian RK, Komoriya A, Meyers CA, Miller DM, Sporn MB. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 1983 Jun 10;258(11):7155–7160. [PubMed]
  • Frolik CA, Dart LL, Meyers CA, Smith DM, Sporn MB. Purification and initial characterization of a type beta transforming growth factor from human placenta. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3676–3680. [PubMed]
  • Roberts AB, Anzano MA, Meyers CA, Wideman J, Blacher R, Pan YC, Stein S, Lehrman SR, Smith JM, Lamb LC, et al. Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry. 1983 Dec 6;22(25):5692–5698. [PubMed]
  • Derynck R, Jarrett JA, Chen EY, Eaton DH, Bell JR, Assoian RK, Roberts AB, Sporn MB, Goeddel DV. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature. 316(6030):701–705. [PubMed]
  • Massagué J, Like B. Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines. J Biol Chem. 1985 Mar 10;260(5):2636–2645. [PubMed]
  • Cheifetz S, Like B, Massagué J. Cellular distribution of type I and type II receptors for transforming growth factor-beta. J Biol Chem. 1986 Jul 25;261(21):9972–9978. [PubMed]
  • Cheifetz S, Weatherbee JA, Tsang ML, Anderson JK, Mole JE, Lucas R, Massagué J. The transforming growth factor-beta system, a complex pattern of cross-reactive ligands and receptors. Cell. 1987 Feb 13;48(3):409–415. [PubMed]
  • Roberts AB, Sporn MB. Transforming growth factors. Cancer Surv. 1985;4(4):683–705. [PubMed]
  • Massagué J. The TGF-beta family of growth and differentiation factors. Cell. 1987 May 22;49(4):437–438. [PubMed]
  • Grubeck-Loebenstein B, Kassal H, Smyth PP, Krisch K, Waldhäusl W. The prevalence of immunological abnormalities in endemic simple goitre. Acta Endocrinol (Copenh). 1986 Dec;113(4):508–513. [PubMed]
  • Londei M, Bottazzo GF, Feldmann M. Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science. 1985 Apr 5;228(4695):85–89. [PubMed]
  • Grubeck-Loebenstein B, Londei M, Greenall C, Pirich K, Kassal H, Waldhäusl W, Feldmann M. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease. J Clin Invest. 1988 May;81(5):1608–1614. [PubMed]
  • Lawrence DA, Pircher R, Krycève-Martinerie C, Jullien P. Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol. 1984 Oct;121(1):184–188. [PubMed]
  • White BA, Bancroft FC. Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples. J Biol Chem. 1982 Aug 10;257(15):8569–8572. [PubMed]
  • Kaczmarek L, Calabretta B, Baserga R. Expression of cell-cycle-dependent genes in phytohemagglutinin-stimulated human lymphocytes. Proc Natl Acad Sci U S A. 1985 Aug;82(16):5375–5379. [PubMed]
  • Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. [PubMed]
  • CHOUFOER JC, VAN RHIJN, KASSENAAR AA, QUERIDO A. ENDEMIC GOITER IN WESTERN NEW GUINEA: IODINE METABOLISM IN GOITROUS AND NONGOITROUS SUBJECTS. J Clin Endocrinol Metab. 1963 Dec;23:1203–1217. [PubMed]
  • Akhurst RJ, Fee F, Balmain A. Localized production of TGF-beta mRNA in tumour promoter-stimulated mouse epidermis. Nature. 1988 Jan 28;331(6154):363–365. [PubMed]
  • Smith KA, Cantrell DA. Interleukin 2 regulates its own receptors. Proc Natl Acad Sci U S A. 1985 Feb;82(3):864–868. [PubMed]
  • O'Connor-McCourt MD, Wakefield LM. Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. J Biol Chem. 1987 Oct 15;262(29):14090–14099. [PubMed]
  • Wrann M, Bodmer S, de Martin R, Siepl C, Hofer-Warbinek R, Frei K, Hofer E, Fontana A. T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta. EMBO J. 1987 Jun;6(6):1633–1636. [PubMed]
Articles from The Journal of Clinical Investigation are provided here courtesy of
American Society for Clinical Investigation